InCarda Therapeutics
Pioneering inhaled medications for cardiovascular conditions
15 employees · est. 2009 · Newark, United States
InCarda Therapeutics is the older company (2009 vs 2018); InCarda Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | InCarda Therapeutics | OncoSpherix |
|---|---|---|
| Founded | ||
| Founded | 2009 older | 2018 |
| Headquarters | ||
| Headquarters | Newark, United States | Atlanta, United States |
| Employees | ||
| Employees | 15 larger | 5 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series C | Grant |
| Total Funding | ||
| Total Funding | $77.88M | $2.92M |
| Funding Rounds | ||
| Funding Rounds | 7 | 8 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cardiovascular, Inhalation Therapy, Pharmaceuticals, Clinical Development, Drug Formulation, Commercialization, Clinical Research, Pre-Clinical Research, Regulatory Affairs | Oncology, Drug Development, Small Molecule Therapeutics, Cancer Treatment, HIF-1 Inhibitors, Solid Tumors, Pre-clinical Stage, Tumor Growth Inhibition, Metastasis Prevention, Survival Prolongation, Mouse Models, Patient Outcomes, Atlanta, Biopharmaceutical |
| Website | ||
| Website | incardatherapeutics.com | oncospherix.com |
About InCarda Therapeutics
InCarda Therapeutics is a clinical stage drug delivery company that is focused on pioneering inhaled medications for cardiovascular conditions. The company's lead product under development is an inhaled therapy designed to treat paroxysmal atrial fibrillation (PAF), a common atrial arrhythmia. InCar...
About OncoSpherix
OncoSpherix is a pre-clinical stage oncology drug development company located in Atlanta, Ga, United States. The company focuses on advancing a proprietary platform of first-in-class small molecule therapeutics designed to target a common feature of solid tumors: the activation of hypoxia inducible...
We will tell you when either one moves
BounceWatch watches InCarda Therapeutics and OncoSpherix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at InCarda Therapeutics and OncoSpherix — by email.
Frequently Asked Questions
Compare InCarda Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at InCarda Therapeutics on 12 Sep 2024, and OncoSpherix on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.